Skip to main content

Mark Podberezin, MD, PhD

Board Certifications

Hematology, Anatomic and Clinical Pathology, Anatomic Pathology


Hematopathology, Surgical Pathology


Hematopathology, Surgical Pathology


ProPath, a Sonic Healthcare anatomic pathology practice, is privileged to include Mark Podberezin, M.D., Ph.D., as a part of its dynamic medical staff. Dr. Podberezin is a triple board-certified pathologist who brings extensive professional experience and a lengthy publication record. 

Dr. Podberezin earned his medical degree at the Tver State Medical Academy in Tver, Russia. He graduated with a doctorate in hematology and transfusion medicine at the National Hematology Center and the Russian Academy of Medical Sciences in Moscow. Dr. Podberezin served an internship in internal medicine at Tver State Medical Academy. This was followed by a fellowship in clinical hematology at the National Hematology Research Center in Moscow. He served a residency in anatomic and clinical pathology at the University of Illinois at Chicago, followed by a surgical pathology fellowship at the same institution. He also completed a fellowship in hematopathology at Houston Methodist Hospital, Baylor College of Medicine, University of Texas MD Anderson Cancer Center, and Harris County Hospital in Houston.

Dr. Podberezin has worked in a variety of healthcare settings. He started as an attending hematologist in the hematology and intensive care department of the National Hematology Center and Russian Academy of Medical Sciences. He held an academic appointment of clinical assistant professor of pathology at University of Saskatchewan in Saskatoon, Canada. While there, he was a staff anatomic pathologist and hematopathologist at Saskatoon Health Region and Royal University Hospital. Dr. Podberezin then took a position at Lahey Clinic in Burlington, Massachusetts, as an anatomic pathologist and hematopathologist. While there, he held an appointment as a clinical assistant professor of pathology at Tufts University in Boston, MA. He held a remote position as a consultant hematopathologist for Advanced Diagnostics/Tesis Labs in Houston. Prior to joining ProPath, Dr. Podberezin was an anatomic pathologist at Forward Pathology Solutions, HCA Healthcare, and Portsmouth Regional Hospital in New Hampshire, and a locum tenens pathologist at Barton Associates in Kankakee, Illinois. 

Dr. Podberezin has published extensively. His manuscripts have been published in journals such as Clinical Thyroidology, Clinical Case Reports, and Advances in Cytology and Pathology, among many others. He has published abstracts in journals and presented them at conferences and professional meetings. He has also been an invited speaker at multiple symposiums, meetings, and professional conferences. 

Dr. Podberezin is a member of the American Society for Clinical Pathology, American Society of Hematology, and the College of American Pathologists, among others.

Dr. Podberezin holds full medical licensure and is board certified in hematology, anatomic and clinical pathology, and anatomic pathology.



Tver State Medical Academy (MD)
Tver, Russia

Russian Academy of Medical Sciences (PhD)
Moscow, Russia

Postgraduate Training

Hematology Fellowship
Houston Methodist Hospital
Baylor College of Medicine
MD Anderson Cancer Center
Harris County Hospital
Houston, TX

Surgical Pathology Fellowship
University of Illinois at Chicago
Chicago, IL

Anatomic and Clinical Pathology Residency
University of Illinois at Chicago
Chicago, IL

Clinical Hematology Fellowship
National Hematology Research Center 
Moscow, Russia

Professional Memberships

American Society for Clinical Pathology
American Society of Hematology
College of American Pathologists
Society for Hematopathology
United States and Canadian Academy of Pathology

Peer-Reviewed Articles

  1. Puchalski A, Willett J, Podberezin M, D'Silva K, Yarlagadda B, Restrepo A. Stage IV Hodgkin's lymphoma with primary presentation as a large thyroid mass. Clin Thyroidol. 2021 Apr 8;33(4):187-193.

  2. Podberezin M, Fitzpatrick MJ, Hariri LP, Sholl L. Malignant peritoneal mesothelioma presenting as a splenic mass. Pathol Res Pract. 2020 Dec;216(12):153273.

  3. Podberezin M, Sohani AR. CD30-positive lymphomatous (nonleukemic) variant of adult T-cell leukemia/lymphoma, HTLV-1 associated. Clin Case Rep. 2020 Jul 20;8(12):2395-2397.

  4. Markland A, Tan B, Adamko D, Diener T, Levett PN, Wiebe S, Wang H, Podberezin M, Saczek K, Milbrandt K, Essalah A, Quan W, Deneer H. Two children with extra-nodal Mycobacterium avium complex infection. Paediatr Child Health. 2020 May 27;26(4):205-207.

  5. Baniak N, Podberezin M, Kanthan S, Kanthan R. Primary pulmonary/pleural melanoma in a 13 year-old presenting as pleural effusion. Pathol Res Pract. 2017;213(2):161-164.

  6. Elshoni H, Stakiw J, Podberezin M. Case study of intracerebral recurrence of plasmablastic myeloma with achievement of complete response after treatment with thalidomide. Advances in Cytology & Pathology. 2017;2(3):1-3.

  7. Podberezin M, Wen J, Chang CC. Cancer stem cells: a review of potential clinical applications. Arch Pathol Lab Med. 2013 Aug;137(8):1111-6.

  8. Podberezin M. A thirty-nine -year-old woman with an abdominal mass. Scripta Medica. 2011;42(1).

  9. Podberezin M, Meriggioli MN, Locante A, Voros A, Valyi-Nagy T, Kajdacsy-Balla A. Hashimoto encephalopathy with fulminant myocarditis. Pathol Res Pract. 2010 Oct 15;206(10):720-2.

  10. Podberezin M, Angeles R, Guzman G, Peace D, Gaitonde S. Primary pancreatic sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): an unusual extranodal manifestation clinically simulating malignancy. Arch Pathol Lab Med. 2010 Feb;134(2):276-8.

  11. Podberezin M, Angeles R, Peace D, Rondelli D, Quigley J, Lindgren V, Gaitonde S. Acute myeloid leukemia with myelodysplasia-related changes: a new entity defined by the WHO 2008 Classification of Hematopoietic and Lymphoid Neoplasms. Laboratory Medicine. 2009;40(7):397-400.

  12. Boles RG, Chaudhari D, Söderkvist J, Podberezin M, Ito M. Quantification of mitochondrial DNA heteroplasmy by temporal temperature gradient gel electrophoresis. Clin Chem. 2003 Jan;49(1):198-200.

  13. Podberezin M, Levina A, Romanova L, Margolin O, Nasibov O, Pivnik AV. Quantitation of red cell-bound immunoglobulins and complement in lymphoma patients. Immunohematology. 2000;16(4):147-53.



  1. Podberezin M. Autoimmune myelofibrosis [case presentation]. Bone marrow workshop. European Association of Hematopathology-Society for Hematopathology Annual Meeting, 2021.

  2. Podberezin M, Kadkol S, Wiley E, Guzman G. Evaluation of microsatellite instability in mucoepidermoid carcinoma [poster 17]. Arch Pathol Lab Med. 2009;133(10):1704.

  3. Podberezin M, Sriprasart T, De Guzman E, Mehendale S, August C. Cardiac epithelioid angiosarcoma with pulmonary metastases presenting as primary pulmonary epithelioid hemangioendothelioma [poster 68]. Arch Pathol Lab Med. 2009;133(10):1699-1700.

  4. Podberezin M, Metelitsa LS, Shimada H, Seeger RC. The role of GPI-linked molecules in neutrophil-mediated ADCC against neuroblastoma cells. Proceedings of the annual meeting of American Association for Cancer Research, New Orleans, LA, 2001.

  5. Podberezin M, Metelitsa LS, Gillies S, Super M, Keshelava N, Seeger RC. Neutrophil ADCC with a humanized anti-GD2/GM-CSF immunocytokine against different neuroblastoma cell lines. Proceedings of the annual meeting of American Association for Cancer Research, San Francisco, CA, 2000.

  6. Podberezin M, de Giorgi L, Booker DJ, Stamps R, Sokol RJ. Evaluation of red cell autoantibodies in patients with primary and secondary autoimmune haemolysis using a chemiluminiscence test. Transfusion Medicine. 1996;6:23.

  7. De Giorgi L, Podberezin M, Booker DJ, Stamps R, Sokol RJ. A chemiluminiscence test for predicting the severity of autoimmune hemolysis. Transfusion Medicine. 1996;6:23.